Fig. 3.

Theoretical coverage provided by type-specific vaccines in Auckland GAS isolates. (a) Coverage for the 30-valent StreptAnova vaccine showing the proportion of isolates with emm-types included (blue) or not-included in the vaccine (red), and assuming cross-opsonisation (mint) or not-cross-opsonised or not tested (lilac). (b) Coverage for the TeeVax vaccine showing the proportion of isolates with tee-types included (blue) or not-included in the vaccine (red), and assuming cross-reactivity (mint) or not-cross-reactive or not tested (lilac). Cross-opsonisation and cross-reactivity as reported.29, 30, 31